ATC Group: D06BB03 Aciclovir

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D06BB03 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D06 Antibiotics and chemotherapeutics for dermatological use
3 D06B Chemotherapeutics for topical use
4 D06BB Antivirals
5 D06BB03 Aciclovir

Active ingredients in D06BB03

Active Ingredient

Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation.

Related product monographs

Document Type Information Source  
 CYCLOVAX Cream MPI, EU: SmPC Υπουργείο Υγείας (CY)
 CYCLOVAX Tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MEDOVIR Cream MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MEDOVIR Powder for solution for infusion MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MEDOVIR Tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 ZOVIRAX Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZOVIRAX Dispersible film-coated tablets MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 Zovirax Eye Ointment MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 Zovirax Intravenous injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines in this ATC group

United States (US)

Albania (AL)

Austria (AT)

Canada (CA)

Croatia (HR)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.